People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Other, Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CrossLiner, Inc. | — | Other | Series A | $23.1M | $60.6M | 2024 |
| Cardio Flow, Inc. | — | Biotechnology | Series A | $20.8M | $2.1M | 2020 |
| Levee Medical, Inc. | — | Healthtech | Series A | $20.3M | $13.5M | 2022 |
Gary McCord at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary McCord on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Turner | 1 | 4 |
| Roger J. Howe | 1 | 3 |
| Gary Petrucci | 1 | 3 |
| Tim Fischell | 1 | 2 |
| Gary M. Petrucci | 1 | 2 |
| Michael J. Kallok | 1 | 2 |
| Mike Henson | 1 | 2 |
| Scott M. Bryant | 1 | 2 |
| Adam Irving | 1 | 1 |
| JIHAD C. MUSTAPHA | 1 | 1 |
| Peter Mulrooney | 1 | 1 |
| Bruce Choi | 1 | 1 |
| Jihad A. Mustapha | 1 | 1 |
| Len Pinchuk | 1 | 1 |
| Marc Monahan | 1 | 1 |
| Mike Mirizzi | 1 | 1 |
| Frank Saltiel | 1 | 1 |
| Steven Simon | 1 | 1 |
| Gary C. McCord | 1 | 1 |
| David Brink | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.